<h1>Legally binding ban on pharma products stalls India-EU investment talks, government to review options and engage regulators.</h1> The Government of India has deferred chief-negotiator talks on the India-EU investment and trade agreement after the EU imposed a legally binding ban on sale of pharmaceutical products clinically tested by an Indian contract research organisation; the Government has engaged EU regulators for eight months, characterises the pharmaceutical sector as a flagship industry with established safety protocols, notes the affected drugs have long been marketed in the EU without adverse pharmacovigilance reports, and will examine all available options.